810143C

14:0 NBD PE

Avanti Research^™ - A Croda Brand 810143C

• Synonym(e): 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt)
• Empirische Formel (Hill-System): C₃₉H₇₀N₅O₁₁P
• CAS-Nummer: 474942-82-0
• Molekulargewicht: 815.97
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: liquid
• Verpackung: pkg of 1 × 1 mL (810143C-1mg); pkg of 5 × 1 mL (810143C-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 810143C
• Konzentration: 1 mg/mL (810143C-1mg); 1 mg/mL (810143C-5mg)
• Versandbedingung: dry ice
• Lagertemp.: −20°C

Beschreibung

Anwendung

14:0 NBD PE is suitable for the preparation of phospholipid vesicles for lipid mixing assay. It is also suitable to use as fluorescent phospholipid derivative to study the effect of its exchange between β-lactoglobulin (β-LG) and phosphatidylcholine (POPC) bilayers.

Biochem./physiol. Wirkung

NBD PE (1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)) can be used liposome preparation. In which, it might serve as a measure of steady-state fluorescence anisotropy. This might be useful to analyse the mitochondrial membrane structure.

Verpackung

5 mL Amber Glass Screw Cap Vial (810143C-1mg)

5 mL Amber Glass Screw Cap Vial (810143C-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• P-Sätze: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system, Liver,Kidney
• WGK: WGK 3